Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types.
Gandara DR, Agarwal N, Gupta S, Klempner SJ, Andrews MC, Mahipal A, Subbiah V, Eskander RN, Carbone DP, Riess JW, Sammons S, Snider J, Bouzit L, Cho-Phan C, Price M, Li G, Quintanilha JCF, Huang RSP, Ross JS, Fabrizio D, Oxnard GR, Graf RP.
Gandara DR, et al.
J Immunother Cancer. 2025 Feb 6;13(2):e010311. doi: 10.1136/jitc-2024-010311.
J Immunother Cancer. 2025.
PMID: 39915003
Free PMC article.